<div id="readability-page-1"><div> <p>(RTTNews) - Sonoma Pharmaceuticals, Inc. (SNOA) priced a $4 million offering of 2.96 million shares and 2.96 million warrants. The offering is priced at $1.35 per share, and the warrants have an exercise price of $1.35 per share.</p> <p>The company expects to use the net proceeds from the offering for general corporate purposes, including working capital.</p> <p>The offering is expected to close on April 27, 2026, subject to customary closing conditions.</p> <p>In addition, Sonoma Pharma has granted Dawson James Securities a 45-day option to purchase up to 15% of the number of shares or warrants sold in the offering solely to cover over-allotments, if any.</p> <p>Sonoma Pharma develops stabilised hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants.   SNOA has traded between $0.85 and $6.92 over the last year. The stock closed Friday's trade at $1.14, down 36.67%.</p> <p>In the pre-market, SNOA is down 0.86% to $1.13. </p> <p>For More Such Biotech Stock News, visit rttnews.com. </p> <p>The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p> </div></div>

SNOA

LABU

SBIO

<p>Sonoma Pharmaceuticals, Inc. (SNOA) has priced a $4 million offering of 2.96 million shares and warrants at $1.35 each. The proceeds will be used for general corporate purposes, including working capital. The offering is set to close on April 27, 2026, pending customary conditions. Additionally, Dawson James Securities has a 45-day option to purchase up to 15% of the offering to cover over-allotments. SNOA's stock closed at $1.14, down 36.67%, and is down 0.86% in pre-market trading.</p>

nasdaq

Sonoma Pharma

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

SPDR S&P Biotech

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Nasdaq

Sonoma Pharma Prices $4 Mln Offering Of Shares And Warrants